Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients.
Sign Up to like & getrecommendations! Published in 2017 at "Gene"
DOI: 10.1016/j.gene.2017.02.013
Abstract: Semaphorin 3A (Sema3A) as an immune modulator could participate in the pathogenesis of autoimmune diseases. In the current study, we aimed to investigate Sema3A expression in peripheral blood mononuclear cells (PBMCs) and its serum level… read more here.
Keywords: immune modulator; sema3a; multiple sclerosis; sema3a immune ... See more keywords